Clinical Study to Test the Efficacy and Safety of ACYC to Treat Moderate to Severe Acne
Public ClinicalTrials.gov record NCT01701024. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, 2-Arm, Parallel Group Comparison Study Comparing the Efficacy and Safety of ACYC and ACYC Vehicle Gel in the Treatment of Acne Vulgaris
Study identification
- NCT ID
- NCT01701024
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Bausch Health Americas, Inc.
- Industry
- Enrollment
- 498 participants
Conditions and interventions
Conditions
Interventions
- ACYC Drug
- ACYC vehicle Drug
Drug
Eligibility (public fields only)
- Age range
- 12 Years to 40 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2012
- Primary completion
- Apr 30, 2013
- Completion
- Jun 30, 2013
- Last update posted
- Jun 3, 2018
2012 – 2013
United States locations
- U.S. sites
- 24
- U.S. states
- 18
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Mobile | Alabama | 36608 | — |
| Not listed | Los Angeles | California | 90045 | — |
| Not listed | San Diego | California | 92123 | — |
| Not listed | New Haven | Connecticut | 06511 | — |
| Not listed | Aventura | Florida | 33180 | — |
| Not listed | Naperville | Illinois | 60563 | — |
| Not listed | Evansville | Indiana | 47714 | — |
| Not listed | South Bend | Indiana | 46617 | — |
| Not listed | Louisville | Kentucky | 40202 | — |
| Not listed | Clinton Township | Michigan | 48038 | — |
| Not listed | Fridley | Minnesota | 55432 | — |
| Not listed | Omaha | Nebraska | 68144 | — |
| Not listed | Albuquerque | New Mexico | 87106 | — |
| Not listed | Rochester | New York | 14623 | — |
| Not listed | Raleigh | North Carolina | 27612 | — |
| Not listed | Portland | Oregon | 97210 | — |
| Not listed | Goodlettsville | Tennessee | 37072 | — |
| Not listed | Austin | Texas | 78759 | — |
| Not listed | College Station | Texas | 77845 | — |
| Not listed | Houston | Texas | 77056 | — |
| Not listed | San Antonio | Texas | 78250 | — |
| Not listed | Salt Lake City | Utah | 84117 | — |
| Not listed | Lynchburg | Virginia | 24501 | — |
| Not listed | Norfolk | Virginia | 23507 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01701024, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 3, 2018 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01701024 live on ClinicalTrials.gov.